Biopharmaceutical Company Elysium Therapeutics Secures $7.5M Funding for Synthetic Opioid Overdose Treatment

Elysium Therapeutics completes funding to advance SOOPR™ technology for preventing and reversing synthetic opioid overdoses.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here